Bonstein Sara
CIK 0001604019
Chief Financial OfficerDirector
Filings
37
Latest May 15, 2026
Issuers covered
3
Showing
37 of 37
Page 1
Track record
37 of 38 open-market trades scored (97% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 37 | 41% | -11.8% | -6.3% | +14.9% | -142.2% |
| 90 days | 37 | 41% | -31.9% | -37.6% | +17.4% | -191.1% |
| 180 days | 33 | 6% | -80.1% | -59.1% | +5.2% | -192.5% |
| 365 days | 21 | 10% | -80.0% | -83.6% | +24.4% | -166.2% |
Issuers
Companies where Bonstein Sara has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| INSM | Insmed Inc | 28 | May 15, 2026 |
| SCPH | Scpharmaceuticals Inc. | 5 | Oct 7, 2025 |
| XLO | Xilio Therapeutics, Inc. | 4 | Jun 12, 2025 |
All filings
37 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|